Date Filed | Type | Description |
10/04/2023 |
8-K
| Appointed a new director |
08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/09/2023 |
8-K
| Quarterly results |
08/02/2023 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
07/18/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
05/26/2023 |
S-3/A
| Form S-3/A - Registration statement under Securities Act of 1933: [Amend] |
05/17/2023 |
8-A12B/A
| Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] |
05/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Departure of Directors or C...
Docs:
|
"Agreement and Plan of Merger by and between KORU Medical Systems, Inc., a New York corporation, and KORU Medical Systems, Inc., a Delaware corporation",
"Certificate of Incorporation of KORU Medical Systems, Inc., a Delaware corporation",
"Bylaws of KORU Medical Systems, Inc., a Delaware corporation" |
|
05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/04/2023 |
8-K
| Quarterly results |
03/29/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/08/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/08/2023 |
8-K
| Quarterly results |
02/24/2023 |
SC 13D/A
| Horton Capital Partners, LLC reports a 21.6% stake in KORU Medical Systems, Inc. |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/09/2022 |
8-K
| Quarterly results |
08/03/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/03/2022 |
8-K
| Quarterly results |
07/06/2022 |
8-K
| Quarterly results |
06/30/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/28/2022 |
8-K
| Quarterly results |
05/18/2022 |
8-K
| Quarterly results |
05/10/2022 |
8-K
| Quarterly results |
05/04/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/04/2022 |
8-K
| Quarterly results |
03/18/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/07/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
03/02/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
03/02/2022 |
8-K
| Quarterly results |
02/14/2022 |
SC 13G
| Archon Capital Management LLC reports a 6.4% stake in Repro Med Systems, Inc. |
02/14/2022 |
SC 13G/A
| First Light Asset Management, LLC reports a 13.3% stake in Repro Med Systems, Inc. |
01/07/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|